← All companies

AVIR

Atea Pharmaceuticals, Inc.

AVIR Nasdaq Pharmaceutical Preparations EDGAR ↗

$4.70

+0.09 +1.95%

Key statistics

from XBRL data in SEC filings

Market cap

$376M

Revenue (TTM)

$351M

Net income (TTM)

-$169M

EPS (TTM)

$-2.11

P/E ratio

—

Dividend yield

—

Free cash flow

-$134M

Cash

$79.3M

Total assets

$267M

Gross margin

—

52-week range

$2.78 – $6.45

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 22, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Results of operations (earnings release) Jan 8, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Entered a material agreement; Results of operations (earnings release); Director or officer change; Regulation FD disclosure Apr 17, 2025 8-K Other events Apr 1, 2025 8-K Other events Mar 24, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Results of operations (earnings release) Mar 6, 2025 8-K Director or officer change Feb 24, 2025 8-K Results of operations (earnings release) Jan 14, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Shareholder vote results Jun 21, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 14, 2024 10-K Fiscal year ended 2023-12-31 Feb 28, 2024 8-K Results of operations (earnings release) Feb 28, 2024 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Results of operations (earnings release) Nov 8, 2023 10-Q Quarter ended 2023-06-30 Aug 8, 2023 8-K Results of operations (earnings release) Aug 8, 2023 8-K Amended charter or bylaws; Shareholder vote results Jun 21, 2023 10-Q Quarter ended 2023-03-31 May 8, 2023 8-K Results of operations (earnings release) May 8, 2023 10-K Fiscal year ended 2022-12-31 Feb 28, 2023 8-K Results of operations (earnings release) Feb 28, 2023 10-Q Quarter ended 2022-09-30 Nov 7, 2022 8-K Results of operations (earnings release) Nov 7, 2022